Efficacy of Inpatient, Evidence-Based Tobacco Use Treatment of Patients With Bladder Cancer After Radical Cystectomy

Overview

Journal Clin Genitourin Cancer

Publisher Elsevier

Specialties Oncology
Urology

Date 2024 Nov 22

PMID 39577125

Authors

Hersh Trivedi

Hannah Kay

Katy Reines

Julie Hartzell

Eiman Newcomer

Shannon Myers

Richard S Matulewicz

Adam O Goldstein

Kimberly A Shoenbill

Marc A Bjurlin

Affiliations

Soon will be listed here.

Abstract

Purpose: Despite a 3-fold increase in risks of bladder cancer (BC) among current smokers, smoking cessation therapy for patients undergoing treatment is significantly underutilized. Inpatient admission after surgery provides a teachable moment to pursue tobacco treatment. We conducted a 12-month prospective quality improvement initiative to increase tobacco treatment program (TTP) consultations with BC patients who smoke and underwent radical cystectomy (RC).

Materials And Methods: From 6/2022 to 6/2023, patients admitted after RC for BC who were identified to be current smokers were referred to our institution's inpatient TTP. A baseline standardized assessment of tobacco dependence was conducted postoperatively, and nicotine replacement therapy (NRT) was prescribed both inpatient and upon discharge. Study endpoints included the percentage of patients receiving inpatient TTP consultation, inpatient and 1-month NRT prescription fill rates, tobacco usage, cessation rates, quit attempts, and patient and provider satisfaction. Postintervention outcomes were compared to historical controls.

Results: Of the 16 inpatients (of 63 RCs) who smoked and received a TTP referral, 15 accepted. Referrals to TTP increased from 20% at baseline to 100% after implementation of the intervention (P = .01). NRT was prescribed for 40% of inpatients, and 60% of patients filled NRT after discharge. At 1-month follow-up, a significant decrease occurred in cigarette use (12.6 cigarettes/day to 6.8 cigarettes/day; P = .001). The majority, 86%, reported attempts to quit, and 29% reported that they successfully quit smoking. Patients reported high levels of stress reduction, confidence to quit, desire to quit, and willingness to use NRT. Most (83%) providers were very satisfied with the TTP and felt recommendations were easy to implement.

Conclusions: This study successfully increased the use of inpatient TTP in patients with BC who smoked and were undergoing RC. The positive outcomes, including high acceptability among patients, increased rates of TTP consultations, reduced cigarette usage postintervention, and notable satisfaction among healthcare providers, suggest that these strategies can be readily adopted by urologic care teams.

References

Sosnowski R, Kamecki H, Bjurlin M, Przewozniak K . The diagnosis of bladder cancer: are we missing a teachable moment for smoking cessation?. Transl Androl Urol. 2019; 8(Suppl 3):S318-S321. PMC: 6642978. DOI: 10.21037/tau.2019.05.15. View

Shields P, Herbst R, Arenberg D, Benowitz N, Bierut L, Luckart J . Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(11):1430-1468. DOI: 10.6004/jnccn.2016.0152. View

Rapoport E, Bjurlin M, Furberg H, Donahue T, Taneja S, Bochner B . Smoking cessation pharmacotherapy use during index hospital admission following cystectomy for bladder cancer: A retrospective cohort study. Urol Oncol. 2022; 41(6):295.e1-295.e8. PMC: 10257731. DOI: 10.1016/j.urolonc.2022.11.013. View

Ostroff J, Garland J, Moadel A, Fleshner N, Hay J, Cramer L . Cigarette smoking patterns in patients after treatment of bladder cancer. J Cancer Educ. 2000; 15(2):86-90. DOI: 10.1080/08858190009528663. View

McBride C, Emmons K, Lipkus I . Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003; 18(2):156-70. DOI: 10.1093/her/18.2.156. View

Chaiton M, Diemert L, Cohen J, Bondy S, Selby P, Philipneri A . Estimating the number of quit attempts it takes to quit smoking successfully in a longitudinal cohort of smokers. BMJ Open. 2016; 6(6):e011045. PMC: 4908897. DOI: 10.1136/bmjopen-2016-011045. View

Farkas A . When does cigarette fading increase the likelihood of future cessation?. Ann Behav Med. 2008; 21(1):71-6. DOI: 10.1007/BF02895036. View

Matulewicz R, Basak R, Zambrano I, Dearing B, Schatz D, El Shahawy O . Patterns of Current Cigarette Smoking, Quit Attempts and Cessation Counseling among Survivors of Smoking-Related and Nonsmoking-Related Urological Malignancies: A Nationally Representative Cross-Sectional Analysis. J Urol. 2020; 205(5):1444-1451. DOI: 10.1097/JU.0000000000001483. View

Rigotti N, Clair C, Munafo M, Stead L . Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012; (5):CD001837. PMC: 4498489. DOI: 10.1002/14651858.CD001837.pub3. View

10.

Stefan M, Pack Q, Shieh M, Pekow P, Bernstein S, Raghunathan K . The Association of Nicotine Replacement Therapy With Outcomes Among Smokers Hospitalized for a Major Surgical Procedure. Chest. 2019; 157(5):1354-1361. PMC: 7268437. DOI: 10.1016/j.chest.2019.10.054. View

11.

Matulewicz R, Meeks W, Mbassa R, Fang R, Pittman A, Mossanen M . Urologists' Perceptions and Practices Related to Patient Smoking and Cessation: A National Assessment From the 2021 American Urological Association Census. Urology. 2023; 180:14-20. PMC: 10592412. DOI: 10.1016/j.urology.2023.06.022. View

12.

Zhao C, Bjurlin M, Roberts T, Rink M, Shariat S, Matulewicz R . A Systematic Review and Scoping Analysis of Smoking Cessation after a Urological Cancer Diagnosis. J Urol. 2021; 205(5):1275-1285. DOI: 10.1097/JU.0000000000001641. View

13.

Chandi J, Soundararajan S, Bukowski W, Britt W, Weiss K, Matulewicz R . Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors. Bladder Cancer. 2024; 10(1):61-69. PMC: 11192552. DOI: 10.3233/BLC-230093. View

14.

Bjurlin M, Goble S, Hollowell C . Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol. 2010; 184(5):1901-6. DOI: 10.1016/j.juro.2010.06.140. View

15.

Ostroff J, Reilly E, Burris J, Warren G, Shelton R, Mullett T . Current Practices, Perceived Barriers, and Promising Implementation Strategies for Improving Quality of Smoking Cessation Support in Accredited Cancer Programs of the American College of Surgeons. JCO Oncol Pract. 2023; 20(2):212-219. PMC: 10911542. DOI: 10.1200/OP.23.00393. View

16.

Brajtbord J, Odisho A, Meng M, Hampson L . Ability of Surgical Residents to Impact Patient Tobacco Use in the Perioperative Setting. Urol Pract. 2023; 3(5):406-411. DOI: 10.1016/j.urpr.2015.08.006. View

17.

Lammers R, Witjes W, Hendricksen K, Caris C, Janzing-Pastors M, Witjes J . Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol. 2011; 60(4):713-20. DOI: 10.1016/j.eururo.2011.07.010. View

18.

Cartmell K, Dismuke C, Dooley M, Mueller M, Nahhas G, Warren G . Effect of an Evidence-based Inpatient Tobacco Dependence Treatment Service on 1-Year Postdischarge Health Care Costs. Med Care. 2018; 56(10):883-889. PMC: 6136961. DOI: 10.1097/MLR.0000000000000979. View

19.

Shi Y, Warner D . Surgery as a teachable moment for smoking cessation. Anesthesiology. 2009; 112(1):102-7. DOI: 10.1097/ALN.0b013e3181c61cf9. View

20.

Hohl S, Matulewicz R, Salloum R, Ostroff J, Baker T, Schnoll R . Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers. J Clin Oncol. 2022; 41(15):2756-2766. PMC: 10331951. DOI: 10.1200/JCO.22.00936. View